Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 170 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Inclisiran Effectiveness in China: a Pragmatic Randomized Trial

 		Coronary Heart Disease Phase4 China NCT06941792

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

 		Glomerulonephritis, IGA, Immunoglobulin A Nephropathy Phase2 Malaysia
United States 		NCT06797518

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

 		Hematologic Malignancy, Solid Tumor, Advanced Malignancies Phase3 Belgium
Italy
Netherlands
United Kingdom
United States
View all
 NCT06401356

Home Reported Outcomes in C3G Study

 		C3 Glomerulopathy United States NCT07029542

Post Marketing Study on Pluvicto in Korea

 		Metastatic Castration-resistant Prostate Cancer South Korea NCT06514521

A Multi-center, Ambispective Cohort Study to Evaluate the Impact of Iptacopan for Adult Patients With PNH in China

 		Paroxysmal Nocturnal Hemoglobinuria China NCT06931691

RWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL)

 		Chronic Myelogenous Leukemia in Chronic Phase Saudi Arabia NCT06684964

A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

 		Hypertension Phase2 Japan
Singapore
United States 		NCT06857955

A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US

 		Immunoglobulin A Nephropathy United States NCT06952426

Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea.

 		Ankylosing Spondylitis South Korea NCT06905288